Ophthalmologist Patricia Bath inducted posthumously into National Inventors Hall of Fame
Dr. Patricia Bath, the first female faculty member in ophthalmology at the David Geffen School of Medicine at UCLA, has been inducted posthumously into the National Inventors Hall of Fame.She and Marian Croak,  vice president of engineering at Google, are the first Black women to be honored by the organization, an achievement noted byNational Public Radio, CNN andFast Company. “Dr. Bath was a trailblazer for women and minorities in the field of ophthalmology,” said Dr. Bartly Mondino, department chair of ophthalmology and director of the UCLA Stein Eye Institute.Bath is credited with in...
Source: UCLA Newsroom: Health Sciences - September 29, 2021 Category: Universities & Medical Training Source Type: news

NHS England medical director warns parents against hoax Covid vaccine letters
The letter, which includes a fake NHS England logo, contains a 'consent checklist' and a number of false assertions about the jab, including that it can cause miscarriages and blindness. (Source: the Mail online | Health)
Source: the Mail online | Health - September 28, 2021 Category: Consumer Health News Source Type: news

Meet The First 2 Black Women To Be Inducted Into The National Inventors Hall Of Fame
Dr. Patricia Bath transformed cataract surgery and fought to eradicate preventable blindness. Marian Croak pioneered the technology behind audio and video conferencing and text-to-donate services. (Image credit: National Inventors Hall of Fame) (Source: NPR Health and Science)
Source: NPR Health and Science - September 27, 2021 Category: Consumer Health News Authors: Rachel Treisman Source Type: news

Penn gene therapy spinout taking on rare retinal diseases launches with $19M in seed funding
A new gene therapy company attempting to commercialize the research of Penn Medicine's Dr. Jean Bennett launched Wednesday in North Carolina with $19 million in seed capital. The company, Opus Genetics, is the first spinout company internally conceived and launched by the Retinal Degeneration Fund (RD Fund), the venture arm of the Foundation Fighting Blindness. The fund was created to further the foundation's mission of backing research to prevent, treat and cure retin al degenerative diseases. Opus… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 22, 2021 Category: American Health Authors: John George Source Type: news

Specialty Pharmacies Cater to the Blind and Those With Impaired Vision
The pandemic has exposed flaws in services for people who can ’t easily access a drive-through window for Covid shots or testing or can’t read prescription labels. (Source: NYT Health)
Source: NYT Health - September 21, 2021 Category: Consumer Health News Authors: Joshua Brockman Tags: Drugs (Pharmaceuticals) Drugstores Disabilities Labeling and Labels (Product) Blindness Coronavirus (2019-nCoV) Braille Containers and Packaging your-feed-science your-feed-healthcare audio-neutral-informative Source Type: news

How Specialty Pharmacies Cater to the Blind and Those With Impaired Vision
The pandemic has exposed flaws in services for people who can ’t easily access a drive-through window for Covid shots or testing or can’t read prescription labels. (Source: NYT Health)
Source: NYT Health - September 21, 2021 Category: Consumer Health News Authors: Joshua Brockman Tags: your-feed-science Drugs (Pharmaceuticals) Drugstores Disabilities Labeling and Labels (Product) Blindness Coronavirus (2019-nCoV) Braille Containers and Packaging your-feed-healthcare audio-neutral-informative Source Type: news

Biogen scores FDA approval for generic eye disease biologic
The Cambridge drugmaker has nabbed an approval from the U.S. Food and Drug Administration for a biosimilar that can treat three disorders causing progressive blindness. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 20, 2021 Category: Pharmaceuticals Authors: Rowan Walrath Source Type: news

Diabetes: The vitamin-packed herb that ‘significantly lowers blood sugar’ levels
THE INCIDENCE of diabetes saw a sharp rise during the pandemic, particularly among children. The condition, which is too often brushed off as benign, comes with a host of complications including amputation, blindness and death. One vitamin-packed herb, however, could lower blood sugar levels by up to a quarter. (Source: Daily Express - Health)
Source: Daily Express - Health - September 20, 2021 Category: Consumer Health News Source Type: news

What Can You Do to Improve Compliance with Eyeglasses or Spectacle Use?
Discussion Uncorrected refractive errors (URE) are a major cause of visual impairment and blindness globally. It is estimated that more than 12.8 million children ages 5-15 years have URE. URE can cause astigmatism, anisometropia, amblyogenic hyperopia and myopia. It can also be a factor in injuries, behavioral problems and academic and social impairments. Spectacles (or eyeglasses or eye wear) are a low-cost, non-invasive, simple to use treatment for URE. Spectacle use has many benefits but depend on end-user use. Learning Point Non-compliance with spectacle use is estimated to be 40.1% overall with a range of 9.8-78.6% i...
Source: PediatricEducation.org - September 20, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Millions with eye conditions at higher risk of dementia, shows research
People with macular degeneration, cataracts and diabetes-related eye disease at greater riskMillions of people with eye conditions including age-related macular degeneration, cataracts and diabetes-related eye disease have an increased risk of developing dementia, new research shows.Vision impairment can be one of the first signs of the disease, which is predicted to affect more than 130 million people worldwide by 2050.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - September 13, 2021 Category: Science Authors: Andrew Gregory Health editor Tags: Medical research Health Dementia Blindness and visual impairment Society Source Type: news

‘A very cruel exit’: UK’s aid cuts risk rapid return of treatable diseases
£200m project to eliminate avoidable blindness and disfigurement in Africa ends after funding is prematurely axedA chandelier sparkling in the background, the grandeur of Downing Street gleaming behind him, Boris Johnson looks into the camera and speaks with solemnity. He is marking World Neglected Tropical Diseases Day, he says, to raise awareness of these “terrible afflictions … which impose an immense burden of suffering in developing countries”.Huge progress has been made, he says, in the fight against the diseases, not least as a result of British aid to some of the poorest parts of the world....
Source: Guardian Unlimited Science - September 13, 2021 Category: Science Authors: Lizzy Davies Tags: Global development Infectious diseases Medical research Microbiology Science Africa Aid World news Blindness and visual impairment Health Source Type: news

Why does Africa have such low rates of severe covid-19 infection and mortality?
(Natural News) In 2015, the Nobel Prize in Physiology and Medicine was awarded to William C. Campbell from the US, Satoshi Omura from Japan, and Youyou Tu from China. The three scientists discovered natural-based remedies to treat parasitic infections that cause malaria, river blindness (onchocerciasis) and elephantiasis (lymphatic filariasis). These infections plague over a hundred... (Source: NaturalNews.com)
Source: NaturalNews.com - September 10, 2021 Category: Consumer Health News Source Type: news

Jewish Healthcare Foundation grants benefit vision, teen programs
The Jewish Healthcare Foundation is providing more than a half million dollars in grants to two Pittsbugh-based programs, one that will bolster artificial intelligence use in the treatment of blindness and the other to foster mental health in teenagers. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - September 3, 2021 Category: American Health Authors: Paul J. Gough Source Type: news

Raleigh startup tackling blindness seeks $19 million haul
A stealthy Raleigh startup tackling blindness is looking to raise millions in venture financing. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - August 23, 2021 Category: American Health Authors: Lauren Ohnesorge Source Type: news

MRNA ’s Next Chapter Has Nothing to Do With COVID-19 Vaccines
It’s safe to say that before the development of the Pfizer-BioNTech and Moderna COVID-19 vaccines, most people hadn’t thought about messenger RNA, or mRNA, since high school science class—if ever. The molecule plays a pivotal role in the body, carrying the recipes for making various proteins to the parts of cells that produce them. But “mRNA” wasn’t exactly a common phrase until Pfizer-BioNTech and Moderna harnessed the genetic material’s power to teach the body to make a piece of a protein found on the COVID-19 virus’ surface, thus training it to fight the real thing, were i...
Source: TIME: Science - August 2, 2021 Category: Science Authors: Jamie Ducharme Tags: Uncategorized healthscienceclimate medicine Source Type: news

MRNA ’s Next Chapter Has Nothing to Do With COVID-19 Vaccines
It’s safe to say that before the development of the Pfizer-BioNTech and Moderna COVID-19 vaccines, most people hadn’t thought about messenger RNA, or mRNA, since high school science class—if ever. The molecule plays a pivotal role in the body, carrying the recipes for making various proteins to the parts of cells that produce them. But “mRNA” wasn’t exactly a common phrase until Pfizer-BioNTech and Moderna harnessed the genetic material’s power to teach the body to make a piece of a protein found on the COVID-19 virus’ surface, thus training it to fight the real thing, were i...
Source: TIME: Health - August 2, 2021 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthscienceclimate medicine Source Type: news

FDA accepts application for Roche ’s faricimab for the treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME)
Basel, 29 July 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has accepted the company ’s Biologics License Application (BLA), under Priority Review, for faricimab for the treatment of neovascular or “wet” age-related macular degeneration (nAMD) and diabetic macular edema (DME). The FDA has also accepted the company’s submission for diabetic retinopathy.Faricimab will be the first and only bispecific antibody designed for the eye, if approved. It targets two distinct pathways – via angiopoietin-2 (Ang-2) and vascular endothelial growt...
Source: Roche Media News - July 29, 2021 Category: Pharmaceuticals Source Type: news

FDA accepts application for Roche ’s faricimab for the treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME)
Basel, 29 July 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has accepted the company ’s Biologics License Application (BLA), under Priority Review, for faricimab for the treatment of neovascular or “wet” age-related macular degeneration (nAMD) and diabetic macular edema (DME). The FDA has also accepted the company’s submission for diabetic retinopathy.Faricimab will be the first and only bispecific antibody designed for the eye, if approved. It targets two distinct pathways – via angiopoietin-2 (Ang-2) and vascular endothelial growt...
Source: Roche Investor Update - July 29, 2021 Category: Pharmaceuticals Source Type: news

Golden Rice: Triumph for Science
By Paul TengSINGAPORE, Jul 28 2021 (IPS) After almost two decades, Golden Rice was approved last week by the Philippines authorities for use as food. This together with the approval of the bioengineered Bt eggplant represents a landmark victory of science over misinformation; it will provide consumers with improved nutrition (Golden Rice) and safer food (Bt eggplant). Paul TengBIOTECHNOLOGY CROPS have been controversial in spite of overwhelming support for their safety by the scientific community. This is specially so for the class of biotechnology crops commonly called ‘GMO’ or genetically modified organism. ...
Source: IPS Inter Press Service - Health - July 28, 2021 Category: International Medicine & Public Health Authors: Paul Teng Tags: Asia-Pacific Biodiversity Climate Change Economy & Trade Environment Food & Agriculture Food Security and Nutrition Headlines Health TerraViva United Nations Source Type: news

New device could help visually impaired avoid obstacles, research suggests
Chest-mounted video camera and vibrating wristbands developed by US team reduce collisions by 37% in small studyVibrating wristbands could help visually impaired people to avoid collisions when out and about, a study indicates.According to the NHS, about 360,000 people in the UK alone are registered as blind or partially sighted, with long canes and guide dogs among the methods used to help individuals avoid obstacles.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - July 22, 2021 Category: Science Authors: Nicola Davis Science correspondent Tags: Blindness and visual impairment Disability Technology Science Source Type: news

BioBonds Use Wall Street Tools to Fund Medical Research
Karen Petrou invented a new funding model for curing blindness. Proposed legislation aims to apply it to medical research more generally. (Source: NYT Health)
Source: NYT Health - July 12, 2021 Category: Consumer Health News Authors: Ephrat Livni Tags: Clinical Trials Drugs (Pharmaceuticals) Law and Legislation Petrou, Karen Shaw Research Lobbying and Lobbyists Health and Human Services Department Rush, Bobby L Fitzpatrick, Brian K (1973- ) Source Type: news

Are you overusing hand sanitizer? Doctors say this could lead to blindness and even death
(Natural News) Medical experts are urging caution and telling Americans not to overuse hand sanitizer, especially if it was not manufactured in the United States. This is because the hand sanitizer might contain one toxic chemical: methanol. Hand sanitizers in the U.S. are banned from using methanol. The Food and Drug Administration (FDA) noted that it is... (Source: NaturalNews.com)
Source: NaturalNews.com - July 8, 2021 Category: Consumer Health News Source Type: news

Artificial intelligence provides faster diagnosis for debilitating blistering disease
(University of Groningen) Scientists at the University of Groningen have trained an Artificial Intelligence system to recognize a specific pattern in skin biopsies of patients with the blistering disease epidermolysis bullosa acquisita. The pattern is characteristic of a specific variant of the disease which can cause scarring of the skin and mucous membranes, and may lead to blindness. The new system is easy to use and is better than most doctors in making the diagnosis. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 8, 2021 Category: International Medicine & Public Health Source Type: news

Hand sanitizer will remain in US households post-pandemic but doctors warn overuse can be dangerous
Experts fear that overuse of hand sanitizer, specifically those that use methanol, can be dangerous over time. Methanol, which is banned in the U.S., can cause blindness or death. (Source: the Mail online | Health)
Source: the Mail online | Health - July 7, 2021 Category: Consumer Health News Source Type: news

Assessing knowledge and practice about eye injuries first aid, with awareness about the importance of early management among general population in Asser Region, 2020 - Dhabaan WA, Almutairi KH, Alzahrani AA, Almutlaq AH, Jali Asiri AAH, Hasan Alshahrani RS, Hadi Jali MA, Alqahtani AMA.
BACKGROUND: Eye injury is a leading cause of monocular blindness and is second only to cataract as the commonest cause of visual impairment. Injury is the commonest reason for eye-related emergency department visits. AIM: To assess population aware... (Source: SafetyLit)
Source: SafetyLit - July 5, 2021 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Roche ’s ENSPRYNG approved by European Commission as first and only at-home subcutaneous treatment for neuromyelitis optica spectrum disorder (NMOSD)
Basel, 28 June 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission (EC) has approved ENSPRYNG ® (satralizumab) for the treatment of adults and adolescents from 12 years of age living with anti-aquaporin-4 antibody (AQP4-IgG) seropositive neuromyelitis optica spectrum disorder (NMOSD), as a monotherapy or in combination with immunosuppressive therapy (IST). ENSPRYNG is the first and only NMO SD treatment that is administered subcutaneously every four weeks, allowing home-dosing after appropriate training.“An NMOSD relapse can be devastating, causing permanent neurological damage ...
Source: Roche Investor Update - June 28, 2021 Category: Pharmaceuticals Source Type: news

Roche ’s ENSPRYNG approved by European Commission as first and only at-home subcutaneous treatment for neuromyelitis optica spectrum disorder (NMOSD)
Basel, 28 June 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Commission (EC) has approved ENSPRYNG ® (satralizumab) for the treatment of adults and adolescents from 12 years of age living with anti-aquaporin-4 antibody (AQP4-IgG) seropositive neuromyelitis optica spectrum disorder (NMOSD), as a monotherapy or in combination with immunosuppressive therapy (IST). ENSPRYNG is the first and only NMO SD treatment that is administered subcutaneously every four weeks, allowing home-dosing after appropriate training.“An NMOSD relapse can be devastating, causing permanent neurological damage ...
Source: Roche Media News - June 28, 2021 Category: Pharmaceuticals Source Type: news

FDA accepts application for Roche ’s Port Delivery System with ranibizumab (PDS) for treatment of neovascular or “wet” age-related macular degeneration (nAMD)
Basel, 24 June 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has accepted the company ’s Biologics License Application (BLA), under Priority Review, for Port Delivery System with ranibizumab (PDS) for the treatment of neovascular or “wet” age-related macular degeneration (nAMD). Neovascular AMD is a leading cause of blindness for people aged 60 and over and impacts approximatel y 20 million people worldwide.1,2,3 If approved, PDS would be a first-of-its-kind therapeutic approach, offering people living with nAMD an alternative to frequent eye i...
Source: Roche Investor Update - June 24, 2021 Category: Pharmaceuticals Source Type: news

FDA accepts application for Roche ’s Port Delivery System with ranibizumab (PDS) for treatment of neovascular or “wet” age-related macular degeneration (nAMD)
Basel, 24 June 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY), today announced that the U.S. Food and Drug Administration (FDA) has accepted the company ’s Biologics License Application (BLA), under Priority Review, for Port Delivery System with ranibizumab (PDS) for the treatment of neovascular or “wet” age-related macular degeneration (nAMD). Neovascular AMD is a leading cause of blindness for people aged 60 and over and impacts approximatel y 20 million people worldwide.1,2,3 If approved, PDS would be a first-of-its-kind therapeutic approach, offering people living with nAMD an alternative to frequent eye i...
Source: Roche Media News - June 24, 2021 Category: Pharmaceuticals Source Type: news

Recycling of the eye's light sensors is faulty in progressive blindness of older adults
(University of Maryland School of Medicine) With the National Eye Institute reporting that about 11 million older adults in the U.S. endure a condition that leads to progressive blindness, known as age-related macular degeneration, University of Maryland School of Medicine (UMSOM) researchers are starting to understand what goes wrong in the disease, in order to develop new therapies to treat it. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - June 23, 2021 Category: International Medicine & Public Health Source Type: news

Inflammation of the eye after drug withdrawal in children with arthritis
(European Alliance of Associations for Rheumatology) Uveitis is an inflammation of the eye and is a common extra-articular manifestation associated with juvenile idiopathic arthritis (JIA). It can cause vision-threatening complications, and if left uncontrolled may even lead to blindness. The majority of children develop uveitis within the first 2 years after arthritis symptom onset, but it can continue into adulthood. This is the first prospective study to analyzed uveitis risk after drug withdrawal, and found that uveitis relapses are common. Rheumatologists and ophthalmologists should be aware and should plan for uveiti...
Source: EurekAlert! - Medicine and Health - June 18, 2021 Category: International Medicine & Public Health Source Type: news

Ultra-thin film could one day turn regular glasses into night vision goggles, researchers say
Developed by Australian and European researchers, the film works by converting infrared light into light visible to the human eyeA transparent metallic film allowing a viewer tosee in the dark could one day turn regular spectacles into night vision googles.The ultra-thin film, made of a semiconductor called gallium arsenide, could also be used to develop compact and flexible infrared sensors, scientists say.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - June 15, 2021 Category: Science Authors: Donna Lu Tags: Science Blindness and visual impairment Health Medical research Source Type: news

2nd progressive vision loss drug by Biogen fails in late-stage trial
Another gene therapy for progressive vision loss developed by Biogen Inc. (Nasdaq: BIIB) has failed in a late-stage clinical trial, the company announced Monday. The drug, designed to target the rare genetic blindness disorder choroideremia, did not show significant benefit 12 months after treatment in a Phase 3 study involving 169 men with the disease. Biogen says it will evaluate the complete dataset before deciding on next steps for the drug's developme nt. This is the second failure in as many… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - June 14, 2021 Category: American Health Authors: Rowan Walrath Source Type: news

Touchless technology could enable early detection and treatment of eye diseases that cause blindness
(University of Waterloo) A new non-contact laser imaging system developed by engineering researchers at the University of Waterloo, is designed to detect telltale signs of major blinding diseases in retinal blood and tissue that typically go unseen until it is too late. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 14, 2021 Category: International Medicine & Public Health Source Type: news

CORRUPTION: Covid-19 mRNA vaccines instruct your cells to CLOG YOUR BLOOD with protein prions that inflame the heart while suffocating the brain
(Natural News) Adverse events and side effects from Covid vaccines include heart inflammation, blood clots, vision changes (blindness), abnormal or total loss of ability to smell and taste, confusion, balance issues, passing out, severe headache and dysphasia. Coincidentally, these are all symptoms of a transient ischemic attack (mini-stroke or ‘TIA’) that occurs when blood flow... (Source: NaturalNews.com)
Source: NaturalNews.com - June 8, 2021 Category: Consumer Health News Source Type: news

AI could soon tell you, how often to see the eye doctor
(Inselspital, Bern University Hospital) Three of the most common chronic eye conditions require regular medical check-ups and injections into the eye by ophthalmology specialists to keep looming blindness at bar. A study by the University of Bern and the Inselspital in collaboration with an AI in eyecare startup now demonstrates that patients' individual ideal frequency for these visits can quite accurately be predicted by machine learning - yielding a threefold benefit. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 8, 2021 Category: International Medicine & Public Health Source Type: news

Epidemiological findings of childhood ocular trauma in a public hospital in Colombia - D'Antone V, Fl órez DCP, García CJL, Manrique FDMC, Barbosa NL.
BACKGROUND: Eye injury is a serious worldwide public health problem that may cause blindness. In children, blindness has functional impact and psychosocial implications. As indicated in many worldwide studies, identification of risk factors associated with... (Source: SafetyLit)
Source: SafetyLit - June 7, 2021 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

West Africa: How the Gambia Beat an Infection That Causes Blindness
[The Conversation Africa] The government of The Gambia recently announced that the country had eliminated trachoma, a highly contagious eye disease, after years of hard work by health workers, nongovernmental organisations (NGOs) and communities. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - June 7, 2021 Category: African Health Source Type: news

Kenya: Blindness, Memory Loss Risk for Diabetic Covid Patients
[Nation] Diabetic patients who got severely ill from Covid-19 and have recovered, or are infected with the virus, are at a higher risk of an infection that can lead to blindness and memory loss. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - May 29, 2021 Category: African Health Source Type: news

Medically Minded Hand Sanitizer – Nationwide Recall Expansion Due to The Presence of Undeclared Methanol
This recall has been initiated due to the presence of undeclared Methanol. Use of or consumption of this product can result in nausea, vomiting, headache, blurred vision, permanent blindness, seizures, coma& or permanent damage to the nervous system or death. Although all persons using these produc (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - May 25, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

A First: Blind Man's Sight Restored With Optogenetic Therapy A First: Blind Man's Sight Restored With Optogenetic Therapy
Combining gene therapy with light-stimulating goggles enabled a patient with a 40-year history of blindness caused by retinitis pigmentosa to regain partial sight.Medscape Medical News (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - May 25, 2021 Category: Emergency Medicine Tags: Neurology & Neurosurgery News Source Type: news

A Blind Patient Regained Partial Sight in a Breakthrough Study, Offering Hope to Millions
The darkness descends slowly for people with retinitis pigmentosa (RP), a degenerative eye disease that affects 2 million people worldwide. The condition is typically diagnosed in childhood or adolescence, but it can take until middle age before a person’s vision has deteriorated severely enough that they are fully or effectively blind. When the lights finally do go out, however, they stay out. Or that’s the way things used to be. In a breakthrough study published today in Nature Medicine, investigators report a relatively simple yet remarkably effective way to restore partial vision to RP patients—one th...
Source: TIME: Health - May 24, 2021 Category: Consumer Health News Authors: Jeffrey Kluger Tags: Uncategorized embargoed study Innovation Source Type: news

A Blind Patient Regained Partial Sight in a Breakthrough Study, Offering Hope to Millions
The darkness descends slowly for people with retinitis pigmentosa (RP), a degenerative eye disease that affects 2 million people worldwide. The condition is typically diagnosed in childhood or adolescence, but it can take until middle age before a person’s vision has deteriorated severely enough that they are fully or effectively blind. When the lights finally do go out, however, they stay out. Or that’s the way things used to be. In a breakthrough study published today in Nature Medicine, investigators report a relatively simple yet remarkably effective way to restore partial vision to RP patients—one th...
Source: TIME: Science - May 24, 2021 Category: Science Authors: Jeffrey Kluger Tags: Uncategorized embargoed study Innovation Source Type: news

Blind Man's Sight Partially Restored with'Optogenetics' Gene Therapy
Using a technique called optogenetics, researchers added light-sensitive proteins to the man ’s retina, giving him a blurry view of objects. (Source: NYT Health)
Source: NYT Health - May 24, 2021 Category: Consumer Health News Authors: Carl Zimmer Tags: Eyes and Eyesight Research Blindness Science and Technology Brain Genetic Engineering Source Type: news

Blind man has sight partly restored after pioneering treatment
Man regains ability to recognise objects in first example of successful optogenetic therapy in humansA blind man has had his sight partly restored after a form of gene therapy that uses pulses of light to control the activity of nerve cells – the first successful demonstration of so-called optogenetic therapy in humans.The 58-year-old man, from Brittany in northern France, was said to be “very excited” after regaining the ability to recognise, count, locate and touch different objects with the treated eye while wearing a pair of light-stimulating goggles, having lost his sight after being diagnosed with r...
Source: Guardian Unlimited Science - May 24, 2021 Category: Science Authors: Linda Geddes Science correspondent Tags: Neuroscience Blindness and visual impairment Medical research Health Society Disability Source Type: news

Transient total blindness associated with alcoholic ketoacidosis - Sato H, Kyan R, Kamada C, Kaku M, Sato S, Tawara T, Sakawaki E, Sakawaki S, Takeyama Y.
We report the case of... (Source: SafetyLit)
Source: SafetyLit - May 22, 2021 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Does age-related macular degeneration (AMD) treatment influence patient falls and mobility? A systematic review - Garrigan H, Hamati J, Lalakia P, Frasso R, Salzman B, Hyman L.
PURPOSE: Age-related macular degeneration (AMD), a leading cause of irreversible blindness, increases fall risk through impaired central vision. Falls place an enormous economic burden on healthcare systems. We hypothesized that AMD treatments may reduce p... (Source: SafetyLit)
Source: SafetyLit - May 20, 2021 Category: International Medicine & Public Health Tags: Age: Elder Adults Source Type: news

Vedere Bio II Launches with $77 Million Series A Financing to Develop Next Generation Ocular Gene Therapies
Uses novel, mutation agnostic optogenetics approach to restore vision in underserved forms of blindness Company backed by leading life science investors including Octagon Capital, Samsara BioCapital and Casdin Capital, along with founding investors Atla... Biopharmaceuticals, Ophthalmology, Venture Capital Vedere Bio II, gene therapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 18, 2021 Category: Pharmaceuticals Source Type: news

Estimated 1 Million Individuals Living With Blindness in the U.S.
MONDAY, May 17, 2021 -- Roughly 7.1 million people are living with visual acuity loss in the United States; and of these individuals, nearly 1.1 million are living with blindness, according to a meta-analysis published online May 13 in JAMA... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 17, 2021 Category: Pharmaceuticals Source Type: news

An amazing revelation about the GOP's willful blindness on Donald Trump
When I read these lines in a Washington Post profile of Wyoming Rep. Liz Cheney over the weekend, I gasped: (Source: Reuters: Health)
Source: Reuters: Health - May 10, 2021 Category: Consumer Health News Source Type: news